{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T09:11:40Z","timestamp":1709889100801},"reference-count":0,"publisher":"National Institute of Public Health NIH (National Research Institute)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Przegl Epidemiol"],"abstract":"<p><strong>ABSTRACT<\/strong><br \/><strong>OBJECTIVE.<\/strong> Analysis of data on hepatitis C, collected as part of epidemiological surveillance in 2018,\u00a0compared to previous years.<br \/><strong>MATERIAL AND METHODS.<\/strong> Analysis of: 1) individual data from surveillance in 2018 2) diagnosis rate from\u00a0bulletins \u201cInfectious diseases and poisonings in Poland\u201d for the years 2012-2018 and 3) data about deaths due to\u00a0hepatitis C from the Demographic Surveys and Labour Market Department of the Central Statistical Office.<br \/><strong>RESULTS.<\/strong> In 2018, there was a decrease in the number of reported hepatitis C cases (3,442 cases) and the\u00a0diagnosis rate (8.96 per 100,000; taking into account the territorial distribution: from 3.29 per 100,000 in the\u00a0Podkarpackie voivodeship to 13.69 per 100,00 in the Lubuskie voivodeship). The disproportion of the rates\u00a0between the sexes returned (in men 9.34 per 100,000 vs. women: 8.61 per 100,000). The disproportion of the\u00a0diagnosis rate depending on the place of residence was still evident (urban: 10.84 per 100,000 vs. rural: 6.12\u00a0per 100,000). There are differences in the values of the diagnosis rates, analyzed in terms of gender, age groups\u00a0and the place of residence. Based on the EU definition, 14 acute hepatitis C were reported, while according to\u00a0the PL definition, 88 cases (0.4% and 2.6% of all reported cases, respectively). HCV infections due to medical\u00a0procedures are still the main route of transmission, also in cases of acute hepatitis C - which indicates the current\u00a0route of transmission. According to the Demographic Surveys and Labour Market Department of the Central\u00a0Statistical Office, 119 deaths related to hepatitis C were reported.<br \/><strong>CONCLUSIONS.<\/strong> For years, the general picture of hepatitis C in Poland, observed through epidemiological\u00a0surveillance, is determined by the availability of testing for HCV infections. The analysis identified subpopulations\u00a0in which primary prevention activities (e.g. safer medical procedures, intensifying activities in the area of harm\u00a0reduction for people who inject drugs) as well as secondary prevention (access to testing and quick inclusion in\u00a0treatment) should be particularly strengthened. According to the micro-elimination strategy, the improvement\u00a0of testing in particularly affected groups, including marginalized populations, is necessary to achieve the WHO\u00a0goal of eliminating HCV by 2030.<\/p>\n<p><strong>STRESZCZENIE<\/strong><br \/><strong>CEL PRACY.<\/strong> Analiza danych dotycz\u0105cych wzw C, zebranych w ramach nadzoru epidemiologicznego w 2018 r.,\u00a0por\u00f3wnuj\u0105ca je do lat ubieg\u0142ych.<br \/><strong>MATERIA\u0141 I METODA.<\/strong> Analiza: 1) indywidualnych danych z nadzoru epidemiologicznego w 2018 2)\u00a0wska\u017anik\u00f3w rozpozna\u0144 z rocznych biuletyn\u00f3w \u201eChoroby zaka\u017ane i zatrucia w Polsce\u201d za lata 2012-2018 oraz 3)\u00a0danych dotycz\u0105cych zgon\u00f3w z powodu wzw C z Departamentu Bada\u0144 Demograficznych i Rynku Pracy G\u0142\u00f3wnego\u00a0Urz\u0119du Statystycznego<br \/><strong>WYNIKI.<\/strong> W 2018 r odnotowano zmniejszenie liczby zg\u0142osze\u0144 wzw C (3 442 przypadki) oraz wska\u017anika\u00a0rozpozna\u0144 wzw C (8,96 na 100 tys. ludno\u015bci; uwzgl\u0119dniaj\u0105c rozk\u0142ad terytorialny: od 3,29 na 100 tys. w wojew\u00f3dztwie\u00a0podkarpackim do 13,69 na 100 tys. w wojew\u00f3dztwie lubuskim). Powr\u00f3ci\u0142a dysproporcja wska\u017anika\u00a0mi\u0119dzy p\u0142ciami (u m\u0119\u017cczyzn 9,34 na 100 tys. vs. u kobiet: 8,61 na 100 tys.). Utrzyma\u0142a si\u0119 dysproporcja warto\u015bci\u00a0wska\u017anika w zale\u017cno\u015bci od \u015brodowiska zamieszkania (mieszka\u0144cy miast: 10,84 na 100 tys. vs. wsi: 6,12 na 100\u00a0tys.). Uwidaczniaj\u0105 si\u0119 r\u00f3\u017cnice w warto\u015bciach wska\u017anika rozpozna\u0144, analizowanego pod k\u0105tem p\u0142ci, grup wieku\u00a0i \u015brodowiska zamieszkania. Na podstawie definicji UE wykazano 14 ostrych wzw C, wg definicji PL 88 przypadk\u00f3w\u00a0(odpowiednio 0,4% i 2,6% wszystkich zg\u0142oszonych). Zaka\u017cenia HCV w zwi\u0105zku z wykonywaniem\u00a0zabieg\u00f3w medycznych wci\u0105\u017c stanowi\u0105 g\u0142\u00f3wn\u0105 drog\u0119 transmisji wirusa, r\u00f3wnie\u017c w przypadkach ostrych wzw\u00a0C \u2013 co \u015bwiadczy o bie\u017c\u0105cej transmisji. Wed\u0142ug Departamentu Bada\u0144 Demograficznych i Rynku Pracy GUS\u00a0w 2018 r. odnotowano 119 zgon\u00f3w zwi\u0105zanych z wzw C.<br \/><strong>WNIOSKI.<\/strong> Od lat obraz wzw C w Polsce, obserwowany w nadzorze epidemiologicznym jest determinowany\u00a0dost\u0119pno\u015bci\u0105 do testowania w kierunku zaka\u017ce\u0144 HCV. Analiza wyodr\u0119bni\u0142a subpopulacje, w kt\u00f3rych szczeg\u00f3lnie\u00a0nale\u017ca\u0142oby wzmocni\u0107 dzia\u0142ania profilaktyki pierwotnej (m.in. uszczelni\u0107 procedury medyczne, intensyfikowa\u0107\u00a0dzia\u0142ania z obszaru redukcji szk\u00f3d dla os\u00f3b przyjmuj\u0105cych substancje w iniekcjach) i wt\u00f3rnej (dost\u0119p\u00a0do testowania i szybkie w\u0142\u0105czanie do program\u00f3w lekowych). Zgodnie z za\u0142o\u017ceniami strategii mikro-eliminacji\u00a0poprawa diagnostyki w grupach szczeg\u00f3lnie dotkni\u0119tych, w tym w grupach zmarginalizowanych jest niezb\u0119dna,\u00a0by osi\u0105gn\u0105\u0107 cel WHO eliminacji HCV do 2030 r.<\/p><\/jats:p>","DOI":"10.32394\/pe.74.17","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T14:15:54Z","timestamp":1603721754000},"page":"209-222","source":"Crossref","is-referenced-by-count":3,"title":["Hepatitis C in Poland in 2018"],"prefix":"10.32394","volume":"74","author":[{"given":"K","family":"Zakrzewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rosi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17323","published-online":{"date-parts":[[2020,10,19]]},"container-title":["Przeglad Epidemiologiczny"],"original-title":["Wirusowe zapalenie w\u0105troby typu C (wzw C) w Polsce w 2018 roku"],"link":[{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-180931-101494","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-180931-101494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:45:32Z","timestamp":1709887532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/Hepatitis-C-in-Poland-in-2018,180931,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["180931"],"URL":"https:\/\/doi.org\/10.32394\/pe.74.17","relation":{},"ISSN":["0033-2100","2545-1898"],"issn-type":[{"value":"0033-2100","type":"print"},{"value":"2545-1898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]}}}